NCT01552837View on ClinicalTrials.gov

Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

December 31, 2010

Conditions
Bipolar Disorder
Interventions
DRUG

Seroquel

for 4 weeks, 300 - 800 mg per day in 2 doses

Trial Locations (1)

52074

Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital Aachen, Aachen

All Listed Sponsors
lead

RWTH Aachen University

OTHER

NCT01552837 - Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology | Biotech Hunter | Biotech Hunter